Skip to Content

Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

MyBillingsClinic

SHARE

Clinical Trials Details

Relapsed, Indolent or Aggressive Non-Hodgkins Lymphoma (NHL)

BAY 80-6946, PI3K inhibitor in patients with relapsed, indolent or aggressive Non-Hodgkin's Lymphoma (NHL)

Objective
  • Follicular Lymphoma grade 1,2,3a
  • Small lymphocytic lymphoma
  • Lymphoplasmacytoid lymphoma/Waldenstrom Macroglobulinemia
  • Marginal zone lymphoma

Relapsed or refractory after equal or greater than 2 prior lines of therapy.  Patients must have received Rituxan.

IRB Protocol Number
BAY 80-6946
Principal Investigator(s)
Brock Whittenberger, MD
Sponsor(s)
Bayer Healthcare
Contact
Linda Allen, RN OCN at 406-435-7481
or lallen@billingsclinic.org

Location

  • Billings Clinic Hospital Fountain Courtyard - South of the Hospital Cafeteria
    2750 9th Ave North
    Billings, MT 59101